< </script> MAS PHARMACY AND HEALTH REVIEW: POST COVID-19 CONSEQUENCES-1. BLACK FUNGUS < </script> <

Pages

Translate

Tuesday, 24 August 2021

POST COVID-19 CONSEQUENCES-1. BLACK FUNGUS

 Black fungus -Description

Covid-19 disease, along with its confusing corticosteroid, and antimicrobial therapies such as chloroquine and azithromycin, has led to the development of fungal infections today.
The patients too no longer have peace.
Also, there is no peace for those who too have recovered from their illness. There is no peace for anyone in the community.
How do such situations develop? The medical world does not have the answer. 
Did this agony suddenly arise or was created with a purpose at the final stage of this twentieth century? 
But don’t just say created. It is a crime.
Still the medical experts do not explain clearly how it came to be. Because it is still in the alphabetical stage of the study says the medical expertise.
There is no need for further proof that the upper ruling class is filled with immoral science and by that, they reign all over the world. The end of the world is near. 
What is  Black Fungus or MUCORMYCETES?
In general, the fungus, bacteria, and viruses are the most vulnerable and weakest creations among all the creatures. These cannot surpass the natural immunity that the Lord has given to our bodies. These overwhelm us only when our immune system is weakened.
The same is true of black fungus.
This black fungus is present in rotten fruits, dirty soil, manure, leaf litter, and animal wastes and in other dirty environments. So it will be ubiquitously related to our body. The body of everyone who can be healthy will develop its immunity accordingly. This resistance is greater for those who live on the sidewalk and in the garbage that can live in the dirt.
But black fungus or mucormycosis, is a rare but dangerous infectious disease that is caused by the loss of immunity in people with diseases such as diabetes mellitus, AIDS, or COVID-19 patients and those recovering from it.
 The disease often affects the skin, lungs, and brain.
The causative agent of this disease is the fungus Mucormycetes.

Disease Types: -

1. Respiratory fungal infections:-
-Cough
-Fever
-Headache
-chest pain
-Nasal or sinus congestion and pain
-wheezing
All of the above symptoms are associated with fungal pneumonia. This is the most dangerous pneumonia.
2. Fungal symptoms related to the skin:-
-Dark skin tissue
-Reddening, swelling, tenderness
-Blisters
-bruises
What happens if a person is affected?: -
Warning symptoms include pain and redness around the eyes or nose, fever, headache, cough, shortness of breath, bloody vomiting and mood swings.
If you have the following symptoms
Black fungal infections should be suspected: -
* Sinusitis - nasal congestion or, heartburn, nasal discharge (black blood);
* Localized pain in the cheekbone, one-sided facial pain, numbness or swelling;
* Black discoloration on bridge of nose / palate;
* Tooth decay, jaw injury;
* With blurred or double vision pain;
* Thrombosis, necrosis, skin ulcer;
* Chest pain, pleural effusion, worsening of respiratory symptoms.
Experts advise that all cases of nasal congestion should not be considered as normal bacterial or viral sinusitis, especially in patients with immunodeficiency due to Covid-19.
Do not hesitate to carry out aggressive tests to detect fungal infections, they advise.
Mucormycosis is not contagious to those with normal immunity, and most people who come in with the fungus cannot easily develop an infectious disease. However, people with a severely weakened immune system have a higher risk of developing mucormycosis. This includes the following patients:-
-Diabetes
-Cancer
-HIV
-Skin injury
-surgery
-COVID-19
General Warnings: -
The sinuses, or lungs, are affected after inhaling fungal spores from the air. In some states, physicians report an increase in the incidence of mucormycosis among those hospitalized for COVID-19 disease or those recovering from COVID-19, some requiring emergency surgery. In general, mucormycetes do not pose a major threat to those with a healthy immune system.
Covid-19 and Mucormycosis (black fungal disease): -
Covid-19 leads to a weakened immune system, preventing the body from effectively protecting itself from infection. As a result, individuals recovering from Covid-19 are at increased risk for mucormycosis.
Christopher Coleman, Assistant Professor of Infectious Diseases, University of Nottingham in the United Kingdom, told Medical News: -
"The virus, as part of its duplication cycle, suppresses the immune system, so the immune system cannot destroy other bacteria or fungi. The most famous example of this is HIV. However, other viruses do this in a very short period of time - that is, other viruses only slightly suppress the immune system for a few days or weeks. 
Steroid treatments for Covit-19 can also suppress the body's immune system. It may also be responsible for the now-increasing rates of mucormycosis infection.
"In this case, there is a suggestion that steroids play an important role," says Coleman. "They suppress the body's normal immune system, allowing a fungus to infiltrate and infect the body."- He further says.
Disadvantages of oxygen therapy:-
Oxygen therapy for severe COVID-19 has been shown to dry out the nasal cavity and increase the risk of fungal infections.
What is the next treatment?: -
There is still no proper treatment for this.
If the patient presents with early symptoms, some antifungal drugs can be given to save him. But in the advanced stage there is no other option but to surgically remove the affected organ or part.
It is difficult to determine the best course of action to treat these two infections simultaneously. Coleman raises some questions, and experts should move this forward:
"Can a patient infected with Covid-19 along with mucormycosis be treated with Covid-19 simultaneously with a fungicide for fungal infections?" And "Is it possible to reduce the dose of Covid-19 treatment and maintain sufficient immunity in the body so that the fungus cannot enter?"
Conclusion: -
The combined risks of Covid-19 and mucormycosis raise challenging issues and require careful coordination

No comments: